Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.
The preclinical drug from Vanqua Bio is designed to inhibit “C5aR1,” a part of the immune system that regulates inflammation.
Bicycling on MSN
Can You Actually "Boost" Your Immune System? Here's How to Actually Stay Healthy Long-Term
You need fewer quick “boosts” to your immunity and more long-term healthy habits, including maintaining strong relationships ...
The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.
Background:Respiratory viruses, including influenza viruses, respiratory syncytial virus (RSV), coronaviruses, and other emerging zoonotic pathogens, remain ...
Prestigious peer-review validates HCB101's differentiated mechanism and translational strength. Clinical data show a nearly ...
STAT Wunderkind Sydney Ramirez is revealing the immune system in our nasal passages and working toward better disease ...
(GLOBE NEWSWIRE) -- (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua’s preclinical, oral C5aR1 antagonist. This agreement ...
Preclinical data support Abalos’ first-in-class approach of safely harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to treat solid tumors -- Düsseldorf, Germany, October 14 ...
A study published in Nature looks at COVID-19 mRNA vaccines and the immune response to tumours during immunotherapy. Prof Andrew Beggs, MRC Senior Clinical Fellow and Consultant Colorectal Surgeon, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback